New Speaker announced for Paediatric Clinical Trials

LONDON - Jan. 16, 2015 - PRLog -- SMi Group are delighted to announce a new speaker for the 2 day event which will review the latest developments in the formulation of medicines for children this spring.

Diana A. van Riet - Nales, Senior Pharmaceutical Assessor at the Medicines Evaluation Board in the Netherlands, will join the expert panel at the Paediatric Clinical Trials conference taking place on 25^th & 26^th March 2015 in London, UK

The presentation entitled: Pharmaceutical development of medicine for children in the PIP and Marketing Authorisation Dossiers, will discuss the basic principles of the guideline on the pharmaceutical development of medicines for paediatric use. Selection of dosage form, the excipients in the preparation, user aspects and regulatory science will also addressed.

Attendees at the 8^th annual show will be able to share ideas with scientific leaders to identify cutting-edge developments including innovative ideas for infectious diseases, new methods for the practical application of physiologically based pharmacokinetic modelling and strategies on cost minimisation and patient recruitment

The conference will also feature case studies from major pharmaceutical companies enabling delegates to gain unique insights into topics such as the administration of medicine through food, approaches for applying PBPK in drug development projects, and the paediatric clinical trial policies used by GSK, Roche and Lundbeck

Keynote addresses will include:

1. MHRA - Population pharmacokinetic and physiologically based pharmacokinetic modelling in paediatric regulatory submissions

2. klausrose Consulting - From the origin of US and EU paediatric legislation to today's PIP challenges

3. Paediatric Committee - Paediatric Clinical Trials in the EU: regulatory perspective

4. GSK - Considerations associated with the use of foods and beverages to assist administration of medicines to children

The full speaker line up and conference agenda is obtainable at www.paediatric-trials.co.uk

Celgene, Novo Nordisk, Takeda and Roche have all recently taken advantage of the conference early bird offer. For those who are interested in attending there is currently a £100 saving available online which expires on January 30^th. Further information is available online at www.paediatric-trials.co.uk

Paediatric Clinical Trials
Reviewing the latest developments in the formulation of medicines for children
25th & 26th March 2015 | Holiday Inn, Regents Park Hotel, London UK
www.paediatric-trials.co.uk